S. KOREA RECEIVES NEW BATCH OF ASTRAZENECA COVID-19 VACCINES

Highlights –

• S. Korea receives new batch of AstraZeneca COVID-19 vaccines.
• S. Korea received new 835,000 doses of AstraZeneca's COVID-19 vaccines.
• S. Korea vaccinated a total of 3.71 million people, or 7.2 percent of the populatio...

NEW DATA SHOWS ASTRAZENECA COVID-19 VACCINE IS 76% EFFECTIVE

Highlights

• The UK-based drugmaker AstraZeneca on Thursday said its vaccine was 76% effective at preventing symptomatic illness

• AstraZeneca on Thursday also reiterated the coronavirus developed by them along with the University of Oxford was 100% effective against...

AstraZeneca, JOHNSON & JOHNSON RESUME COVID VACCINE TRIALS IN U.S.

Highlights

• AstraZeneca said the Food and Drug Administration (FDA) today authorized the restart in the U.S., following the resumption of trials in other countries in recent weeks

• The drugmaker further said that the FDA reviewed all safety data from trials globall...

ASTRAZENECA US COVID-19 VACCINE TRIAL LIKELY TO RESUME THIS WEEK

Highlights

• Late-stage US trial of AstraZeneca's COVID-19 vaccine were put on hold since September 6 after a participant in the company’s UK trial fell ill with a suspiciously rare spinal inflammatory disorder known as transverse myelitis

• Sources claim t...

US LIKELY TO BUY ALL DOSES OF UK’S AstraZeneca-OXFORD COVID-19 VACCINE

Highlights

• The US President Donald Trump has directed defence and health chiefs to ensure that the US is the first in the list to get UK's COVID-19 vaccine currently developed by pharmaceutical company AstraZeneca along with the University of Oxford

• The Ameri...

FDA REPORTEDLY EXPANDING ITS INVESTIGATION OF ASTRAZENECA COVID-19 VACCINE TRIAL

Highlights

• Reports state that by expanding its probe into the unexplained illness, the FDA will be looking into trials conducted at earlier stages of similar vaccines developed by the same scientists

• One of the source has claimed that with this investigation, the...

COVID-19 VACCINE: SERUM INSTITUTE OF INDIA TO COMMENCE PHASE II TRIAL OF OXFORD VACCINE TODAY

According to the sources, the phase II human clinical trial of the Oxford COVID-19 vaccine candidate by the Serum Institute of India (SII), Pune will start from today. Bharati Vidyapeeth Medical College and Hospital in Pune is the site where this observer-blind, randomised controlled study to det...

COVID-19 VACCINE: SERUM INSTITUTE OF INDIA TO BEGIN PHASE 2 TRIALS OF OXFORD VACCINE THIS WEEK

Highlights

• The Serum Institute of India has stated that it has shortlisted 10 centres across the nation to conduct Phase II and Phase III human clinical trials of COVID-19 vaccine developed by the University of Oxford

• On Monday, the national expert group on vacci...

COVID-19 VACCINE: DCGI APPROVES PHASE 2 AND 3 CLINICAL TRIALS OF OXFORD VACCINE BY SERUM INSTITUTE

Highlights

• DCGI Dr V G Somani granted approval for conducting phase 2 and 3 human clinical trials by the SII

• ‘Covishield’ a potential vaccine for COVID-19 has been developed by the University of Oxford

• Before starting the phase 3 tria...

JAPAN WANTS TO SECURE CORONAVIRUS VACCINE

HIGHLIGHTS

• Daiichi Sankyo is talking to AstraZeneca to secure Japan supplies of a potential coronavirus vaccine.
• The vaccine is called AZD1222.

Japanese pharmaceutical company Daiichi Sankyo is in discussions with British pharmaceuti...